Currently, animal experimentation is on a trend toward replacement.
Globally, various testing methods that fully or partially replace animals are being developed and implemented, particularly in fields such as toxicity testing, neuroscience, and drug development.
Experiments can be conducted without using animals, utilizing alternatives such as organoids
(human organ-like structures), organ chips, and harvested animal tissues.
These alternative methods are becoming established as effective substitutes for animal experimentation, combining advanced technology with ethical considerations.
Animal replacement experiments refer to the application of alternative methods and strategies to achieve scientific purposes without using animals or minimizing their use.
This is considered important not only for ethical reasons but also for scientific, economic, and environmental considerations.
Animal experiments often cause harm to animals, leading to ethical concerns about animal rights.
Animal replacement experiments are considered an attempt to minimize these ethical issues.
Animal models may not fully replicate human biological responses in specific environments.
Animal replacement experiments introduce new experimental techniques and in vitro models to obtain more accurate and predictable results.
Animal experiments can be costly, and the complex maintenance and ethical issues can lead to increased research expenses.
Animal replacement experiments can reduce research costs and enhance efficiency.
Animal experiments can have environmental impacts due to the resources and energy required for animal care.
Animal replacement experiments are considered an attempt to minimize these environmental impacts.
Animal replacement experiments encompass various experimental platforms, including cell culture,
modeling using artificial intelligence and machine learning, and human resources.
Some countries enforce legal regulations recommending or mandating animal replacement experiments,
considering ethical issues and scientific limitations associated with animal experiments.
Animal replacement experiments refer to the application of alternative methods and strategies to achieve scientific purposes without using animals or minimizing their use.
This is considered important not only for ethical reasons but also for scientific, economic, and environmental considerations.
Animal experiments often cause harm to animals, leading to ethical concerns about animal rights.
Animal replacement experiments are considered an attempt to minimize these ethical issues.
Animal models may not fully replicate human biological responses in specific environments.
Animal replacement experiments introduce new experimental techniques and in vitro models to obtain more accurate and predictable results.
Animal experiments can be costly, and the complex maintenance and ethical issues can lead to increased research expenses.
Animal replacement experiments can reduce research costs and enhance efficiency.
Animal experiments can have environmental impacts due to the resources and energy required for animal care.
Animal replacement experiments are considered an attempt to minimize these environmental impacts.
Animal replacement experiments encompass various experimental platforms, including cell culture,
modeling using artificial intelligence and machine learning, and human resources.
Some countries enforce legal regulations recommending or mandating animal replacement experiments,
considering ethical issues and scientific limitations associated with animal experiments.
Organoid refers to a three-dimensional mini-organ artificially created in vitro, reproducing the cellular composition, structure, and functional specificity of the organ. We provide highly qualified state-of-the-art 3D organoid modeling solutions, seamlessly combining cutting-edge technologies.
Lambda’s innovative, next-generation anti-cancer drug efficacy evaluation platform is based on patient-derived organoids(PDOs).
This platform allows for the assessment of the efficacy of anticancer agents and immunotherapeutics by utilizing co-culture systems with tumor microenvironment components.
In alignment with the global ban on animal testing for cosmetics, our approach is to employ advanced methodologies such as 2D cell cultures and artificial skin tests.
We offer meticulously controlled and curated skin testing solutions to meet the stringent demands of the cosmetics industry.
Furthermore, our expertise extends to providing access to hair follicle-bearing skin organoid models, offering a comprehensive platform for evaluating the efficacy and safety of cosmetic formulations.
‘Spatial biology’ is a research field that seeks to understand the spatial structure and interactions of various biological components, such as cells, proteins, and genes, within biological samples. It allows for a deep 2D or 3D visual understanding of cell-cell interactions and their positioning.
Toxicology is a significant factor contributing to the attrition in the development of therapeutic drugs, and it is a crucial consideration when selecting candidate drugs to progress through the development pipeline.
Expanding preclinical testing to better predict potential toxicity in the early stages of development has clear advantages in choosing successful lead candidates. Integrating analytical methods to better predict potential toxicity in the early stages of development has clear advantages in choosing successful lead candidates.
We leverage cutting-edge technologies and specialized expertise to provide services across various research fields, allowing for exploration in diverse topics and domains. Tailoring our services to meet the specific needs and goals of our clients, we aim to deliver customized solutions that lead to optimal research outcomes.
Lambda Biologics GmbH
Deutscher Pl. 5c, 04103 Leipzig, Germany
